We report the synthesis of new anti-inflammatory
1,7-dihydropyrazolo[3′,4′:4,5]pyrimido[1,6-a]pyrimidine 5 from aminocyanopyrazole. All compounds were characterized by physical,
chemical and spectral studies. Preliminary pharmacological evaluation of the resulting products
showed that compounds 5a, b,
f (50–100 mg/kg, i.p) are active anti-inflammatory agents in
carrageenan-induced rat paw oedema assay, and their effects are comparable to that of
acetylsalicylic–lysine (300 mg/kg, i.p.), used as a reference drug. The nature of substituent (Y,
R3) had a pronounced effect on the anti-inflammatory activity. Studies of
structure–activity relationships have led to selection of compound
ethyl-3,5-dimethyl-7-imino-N1-phenyl-1,7-dihydropyrazolo[3′,4′:4,5]pyrimido[1,6-a]pyrimidine-6-carboxylate, 5f which
exhibited the most potent anti-inflammatory activity. In addition, the compounds 5a, b, f
showed a significant gastroprotective effect against HCl/EtOH-induced gastric ulcer.